We are monitoring the impact of COVID-19 & Recession alarm on Asia Pacific Atopic Dermatitis Market Get in touch with us for detailed analysis Know More

Know More

Share on

Asia Pacific Atopic Dermatitis Market Research Report – Segmented By Treatment Type, Route of Administration, Distribution Channel & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 5172
Pages: 145

Asia Pacific Atopic Dermatitis Market Size (2022 to 2027):

The size of the Atopic Dermatitis Market in the Asia Pacific is forecasted to grow USD 5.02 billion by 2027 from USD 2.63 billion in 2022, hiking at a CAGR of 13.8% from 2022 to 2027.

Y-O-Y growth in the incidence of atopic dermatitis in children in the Asia Pacific countries is predicted to enhance the region's market growth. The on-going efforts made by the key players for the development of novel drugs are driving market growth. Regular increases in disorders among the emerging economies are driving the growth. Growing healthcare expenses per head and upgraded health insurance coverage are stimulating the growth of the APAC region. An increase in discretionary expenses, climatic changes, and escalating pollution levels and research institutes and pharmaceutical companies' research and development efforts lead to the development of new drugs in the region.

The cost of biologics is predicted to impede the market in both developed and underdeveloped countries. Lack of awareness in patients, uptake of generic topical drugs, and pediatric population existing as the most massive segment act as an obstacle in the region's market growth. Curbing from the approval process for new drugs is inhibiting market growth.

This research report on the Asia Pacific Atopic Dermatitis Market has been segmented and sub-segmented into the following categories:

By Treatment Type:

  • Drug Treatment
  • Radiation Treatment

By Route of Administration:

  • Topical
  • Oral

By Distribution Channel:

  • Hospital pharmacies
  • retail pharmacies
  • online pharmacies

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

The Asia Pacific Atopic Dermatitis Market is predicted to be the fastest-growing market in the forecast mentioned above period. Rapidly growing population, changing lifestyles, and a paradigm shift towards western lifestyles, increasing R&D, and large target patient pool are the reasons attributable to the observable trend mentioned above.

Countries like India, China, and South Korea are to invest highly in the healthcare domain. India and South Korea are to produce considerable demand for atopic dermatitis treatment in the region. In India, around 20-30% of the population is suffering from at least one allergic disease. Key players of this region are to make considerable investments in the research and development of new drugs is to accelerate the market. China is expected to lead the atopic dermatitis market in the APAC region due to rising awareness of skin problems in infants and small children. Uplifting healthcare infrastructure and services scenario among the developing economies and existence of enormous targeted patient count and considerable growth in generic drugs for the market, making a substantial contribution to the development of emerging countries like India, South Korea, and China. Other factors like seasonal allergies, severe climatic conditions, and varying humidity levels boost the region's growth.

Companies that are leading the Asia Pacific Atopic Dermatitis Market Profiled in the Report are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment Type                       

                                5.1.1 Introduction           

                                5.1.2 Drug Treatment    

                                                5.1.2.1 Emollients

                                                5.1.2.2 Antihistamines

                                                5.1.2.3 Antibiotics

                                                5.1.2.4 Corticosteroids

                                                5.1.2.5 Calcineurin Inhibitors

                                5.1.3 Radiation Treatment           

                                5.1.4 Y-o-Y Growth Analysis, By Treatment Type               

                                5.1.5 Market Attractiveness Analysis, By Treatment Type             

                                5.1.6 Market Share Analysis, By Treatment Type              

                5.2 Route of administration                        

                                5.2.1 Introduction           

                                5.2.2 Topical      

                                5.2.3 Oral            

                                5.2.4 Y-o-Y Growth Analysis, By Route of administration               

                                5.2.5 Market Attractiveness Analysis, By Route of administration             

                                5.2.6 Market Share Analysis, By Route of administration               

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Retail Pharmacies 

                                5.3.4 Online Pharmacies               

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.6 Market Attractiveness Analysis, By Distribution Channel    

                                5.3.7 Market Share Analysis, By Distribution Channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment Type

                                                6.1.3.3 By Route of administration

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment Type

                                                6.1.4.3 By Route of administration

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment Type

                                                6.1.5.3 By Route of administration

                                                6.1.5.4 By Distribution Channel

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Astellas Pharma Inc.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Sanofi S.A.                  

                8.3 Valeant Pharmaceuticals International, Inc.                 

                8.4 Novartis International AG                    

                8.5 Pfizer Inc.                    

                8.6 Meda Pharmaceuticals                          

                8.7 Regeneron Pharmaceuticals Inc.                       

                8.8 Anacor Pharmaceuticals, Inc.                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia Pacific Atopic Dermatitis Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  2. Asia Pacific Drug Treatment Market By Region, From 2022 to 2027 ( USD Billion )
  3. Asia Pacific Radiation Treatment Market By Region, From 2022 to 2027 ( USD Billion )
  4. Asia Pacific Atopic Dermatitis Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  5. Asia Pacific Topical Market By Region, From 2022 to 2027 ( USD Billion )
  6. Asia Pacific Oral Market By Region, From 2022 to 2027 ( USD Billion )
  7. Asia Pacific Atopic Dermatitis Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  8. Asia Pacific Hospital Pharmacies Market By Region, From 2022 to 2027 ( USD Billion )
  9. Asia Pacific Retail Pharmacies Market By Region, From 2022 to 2027 ( USD Billion )
  10. Asia Pacific Online Pharmacies Market By Region, From 2022 to 2027 ( USD Billion )
  11. Japan Atopic Dermatitis Treatment Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  12. Japan Atopic Dermatitis Treatment Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  13. Japan Atopic Dermatitis Treatment Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  14. China Atopic Dermatitis Treatment Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  15. China Atopic Dermatitis Treatment Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  16. China Atopic Dermatitis Treatment Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  17. India Atopic Dermatitis Treatment Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  18. India Atopic Dermatitis Treatment Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  19. India Atopic Dermatitis Treatment Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  20. Australia Atopic Dermatitis Treatment Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  21. Australia Atopic Dermatitis Treatment Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  22. Australia Atopic Dermatitis Treatment Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  23. South Korea Atopic Dermatitis Treatment Market By Treatment Type, From 2022 to 2027 ( USD Billion )
  24. South Korea Atopic Dermatitis Treatment Market By Route of Administration, From 2022 to 2027 ( USD Billion )
  25. South Korea Atopic Dermatitis Treatment Market By Distribution Channel, From 2022 to 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample